1-4 of 4
nephrology
Close
Sort by
Journal Articles

Trends in ADAMTS13 Activity Testing over the Last 7 Years in a Single UK TTP Specialist Centre

Kat Moss, MBBS, MRCP, Colin Downey, Ashley Lawrenson, Tina Dutt, PhD MBBS, BSc, FRCPath, FRCP, Rebecca J Shaw
Journal: Blood
Blood (2018) 132 (Supplement 1): 3526.
https://doi.org/10.1182/blood-2018-99-119331
Published: 2018
Journal Articles

Treatment of Myeloma Cast Nephropathy (MCN): A Randomized Trial Comparing Intensive Haemodialysis (HD) with High Cut-Off (HCO) or Standard High-Flux Dialyzer in Patients Receiving a Bortezomib-Based Regimen (the MYRE Study, by the Intergroupe Francophone du Myélome (IFM) and the French Society of Nephrology (SFNDT))

Frank Bridoux, MD PhD, Brigitte Pegourie, MD, Karine Augeul-Meunier, MD, Bruno Royer, MD, Bertrand Joly, MD, Thierry Lamy, MD PhD, Brigitte Kolb, Lofti Benboubker, Bertrand Arnulf, MD, Arnaud Jaccard, MD PhD, Sylvie Chevret, Jean-Paul Fermand, MD
Journal: Blood
Blood (2016) 128 (22): 978.
https://doi.org/10.1182/blood.V128.22.978.978
Published: 2016
Journal Articles

Case Mix of Nonmalignant Hematology in Inpatient Hematology/Oncology Consultation: Review of a 14 Month Experience from a Single University/Community Hybrid Hospital

Robert T Means, MD
Journal: Blood
Blood (2014) 124 (21): 5974.
https://doi.org/10.1182/blood.V124.21.5974.5974
Published: 2014
Journal Articles

Evaluating Mortality with Erythropoietic Stimulating Agents (ESAs) in the Nephrology Setting: The Distinction between Evaluating Trials That Measure Survival as a Primary or Secondary Efficacy Endpoint Versus a Safety Endpoint.

Sara E. Barnato, MD, Charles L. Bennett, MD PhD MPP, Kathleen Elverman, Dennis P. West, PhD, Mark Courtney, MD
Journal: Blood
Blood (2007) 110 (11): 962.
https://doi.org/10.1182/blood.V110.11.962.962
Published: 2007